← Back to screener

GERON CORP GERN

Rank #2490 · Nasdaq · $0.6B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
13.7
P/E
-3.1
P/B
7.17
ROE
-230.2%
Op. Margin
–%
Debt Ratio
392%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -3.1x, P/B 7.17x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -230.2%. Ranks in the top 98% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 392%. Ranks in the top 76% of the universe. Above 200% signals meaningful leverage risk.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Valuation is the relative strength (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B$-0.1B$-0.1B$0.2B-4069.239
2012$0.0B$-0.1B$-0.1B$0.2B-3120.0-7
2013$0.0B$-0.1B$-0.1B$0.2B-3942.4-48
2014–$-0.1B$-0.1B$0.1B–-54
2015$0.0B$-0.0B$-0.0B$0.1B-3036.5101
2016$0.0B$-0.0B$-0.0B$0.1B-3149.3149
2017$0.0B$-0.0B$0.0B$0.1B-1.5-0
2018$0.0B$-0.0B$-0.0B$0.1B-497.3-22
2019$0.0B$-0.0B$-0.0B$0.1B-2746.951
2020$0.0B$-0.0B$-0.0B$0.1B-2914.929
2021$0.0B$-0.1B$-0.1B$0.2B-15762.034
2022$0.0B$-0.1B$-0.1B$0.1B-30400.474
2023$0.0B$-0.1B$-0.1B$0.2B-8183.752
2024–$-0.1B$-0.1B$0.1B–116
2025–$-0.2B$-0.2B$0.1B–392

← See the full screener